Abstract
Background: Cellular tropism of human immunodeficiency virus (HIV-1) is closely linked to interactions between the viral envelope glycoprotein (Env) with CD4 and chemokine receptor family members, CCR5 and CXCR4. This interaction plays a key role in determining anatomic sites that are infected in vivo and the cascade of early and late events that result in chronic immune activation, immunosuppression and ultimately, AIDS. CD4+ T cells are critical to adaptive immune responses, and their early and rapid infection in gut lamina propria and secondary lymphoid tissues in susceptible hosts likely contributes to viral persistence and progression to disease. CD4+ macrophages are also infected, although their role in HIV-1 pathogenesis is more controversial.
Methods: Pathogenic infection by simian immunodeficiency viruses (SIV) in Asian macaques as models of HIV-1 infection has enabled the impact of cellular tropism on pathogenesis to be directly probed. This review will highlight examples in which experimental interventions during SIV infection or the introduction of viral mutations have altered cellular tropism and, subsequently, pathogenesis.
Results: Alterations to the interaction of Env and its cellular receptors has been shown to result in changes to CD4 dependence, coreceptor specificity, and viral tropism for gut CD4+ T cells and macrophages.
Conclusion: Collectively, these findings have yielded novel insights into the critical role of the viral Env and tropism as a driver of pathogenesis and host control and have helped to identify new areas for targeted interventions in therapy and prevention of HIV-1 infection.
Keywords: Tropism, pathogenesis, SIV, CD4, CXCR4, CCR5, macrophage, CD4-independence.
Graphical Abstract
[1]
Council O, Joseph SB. Evolution of Host Target Cell Specificity During HIV-1 Infection. Curr HIV Res 2017. In press
[2]
Lackner AA, Lederman MM, Rodriguez B. HIV pathogenesis: The host. Cold Spring Harb Perspect Med 2012; 2: a007005.
[3]
Wetzel KS, Elliott STC, Collman RG. SIV Coreceptor Specificity in Natural and Non-Natural Host Infection: Implications for Cell Targeting and Differential Outcomes from Infection. Curr HIV Res 2017. In press
[4]
Li Q, Duan L, Estes JD, et al. Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 2005; 434(7037): 1148-52.
[5]
Boggiano C, Manel N, Littman DR. Dendritic cell-mediated trans-enhancement of human immunodeficiency virus type 1 infectivity is independent of DC-SIGN. J Virol 2007; 81: 2519-23.
[6]
Hladik F, Sakchalathorn P, Ballweber L, et al. Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity 2007; 26: 257-70.
[7]
Hu J. Gardner Mb, Miller CJ. Simian Immunodeficiency Virus Rapidly Penetrates the Cervicovaginal Mucosa after Intravaginal Inoculation and Infects Intraepithelial Dendritic Cells. J Virol 2000; 74(13): 6087-95.
[8]
Sewald X, Ladinsky MS, Uchil PD, et al. Retroviruses use CD169-mediated trans-infection of permissive lymphocytes to establish infection. Science 2015; 350: 563-7.
[9]
Iyer SS, Bibollet-Ruche F, Sherrill-Mix S, et al. Resistance to type 1 interferons is a major determinant of HIV-1 transmission fitness. Proc Natl Acad Sci USA 2017; 114: E590-9.
[10]
Veazey RS, DeMaria M, Chalifoux LV, et al. Gastrointestinal tract as a major site of CD4 T cell depletion and viral replication in SIV infection. Science 1998; 280: 427-31.
[11]
Miller CJ, Li Q, Abel K, et al. Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus. J Virol 2005; 79: 9217-27.
[12]
Schieferdecker HL, Ullrich R, Hirseland H, Zeitz M. T cell differentiation antigens on lymphocytes in the human intestinal lamina propria. J Immunol 1992; 149: 2816-22.
[13]
MacDonald TT, Spencer J. Lymphoid cells and tissues of the gastrointestinal tract. In: Heatley RH, Ed. Gastrointestinal and hepatic immunology. Cambridge: Cambridge University Press 1994; pp. 1-23.
[14]
Brenchley JM, Schacker TW, Ruff LE, et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 2004; 200: 749-59.
[15]
Mehandru S, Poles MA, Tenner-Racz K, et al. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med 2004; 200: 761-70.
[16]
Veazey RS, Marx PA, Lackner AA. Importance of the state of activation and/or differentiation of CD4+ T cells in AIDS pathogenesis. Trends Immunol 2002; 23: 129.
[17]
Arthos J, Cicala C, Martinelli E, et al. HIV-1 envelope protein binds to and signals through integrin alpha4beta7, the gut mucosal homing receptor for peripheral T cells. Nat Immunol 2008; 9: 301-9.
[18]
Guzzo C, Ichikawa D, Park C, et al. Virion incorporation of integrin a4B7 facilitates HIV-1 infection and intestinal homing. Sci Immunol 2017; 2: 1-12.
[19]
Veazey RS, Tham IC, Mansfield KG, et al. Identifying the target cell in primary simian immunodeficiency virus (SIV) Infection: highly activated memory CD4+ T Cells are rapidly eliminated in early SIV infection in vivo. J Virol 2000; 74: 57-64.
[20]
Mattapallil JJ, Douek DC, Hill B, et al. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 2005; 434: 1093-7.
[21]
Brenchley JM, Paiardini M, Knox KS, et al. Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 2008; 112(7): 2826-35.
[22]
Ryan ES, Micci L, Fromentin R, et al. Loss of Function of Intestinal IL-17 and IL-22 Producing Cells Contributes to Inflammation and Viral Persistence in SIV-Infected Rhesus Macaques. PLoS Pathog 2016; 12: e1005412.
[23]
Estes JD, Harris LD, Klatt NR, et al. Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS Pathog 2010; 6: e1001052.
[24]
Cubas RA, Mudd JC, Savoye AL, et al. Inadequate T follicular cell help impairs B cell immunity during HIV infection. Nat Med 2013; 19: 494-9.
[25]
Perreau M, Savoye AL, De Crignis E, et al. Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production. J Exp Med 2013; 210: 143-56.
[27]
Connick E, Mattila T, Folkvord JM, et al. CTL Fail to Accumulate at Sites of HIV-1 Replication in Lymphoid Tissue. J Immunol 2007; 178: 6975-83.
[28]
Petrovas C, Ferrando-Martinez S, Gerner MY, et al. Follicular CD8 T cells accumulate in HIV infection and can kill infected cells in vitro bia bispecific antibodies. Sci Transl Med 2017; 9: 1-14.
[29]
Roberts ER, Carnathan DG, Li H, et al. Collapse of cytolytic potential in SIV-Specific CD8+ T cells following acute SIV infection in rhesus macaques. PLoS Pathog 2016; 12: e1006135.
[30]
Fukazawa Y, Lum R, Okoye AA, et al. B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers. Nat Med 2015; 21(2): 132-9.
[31]
Connor RI, Sheridan KE, Ceradini D, Choe S, Landau NR. Change in coreceptor use correlates with disease progression in HIV-1 - infected individuals. J Exp Med 1997; 185: 621-8.
[32]
Moore JP, Kitchen SG, Pugach P, Zack JA. The CCR5 and CXCR4 coreceptors - central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses 2004; 20: 111-26.
[33]
Chahroudi A, Bosinger SE, Vanderford TH, Paiardini M, Silvestri G. Natural SIV hosts: showing AIDS the door. Science 2012; 335: 1188-93.
[34]
Ping LH, Joseph SB, Anderson JA, et al. Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design. J Virol 2013; 87: 7218-33.
[35]
Schnell G, Joseph S, Spudich S, Price RW, Swanstrom R. HIV-1 replication in the central nervous system occurs in two distinct cell types. PLoS Pathog 2011; 7(10): e1002286.
[36]
Calantone N, Wu F, Klase Z, et al. Tissue myeloid cells in SIV-infected primates acquire viral DNA through phagocytosis of infected T cells. Immunity 2014; 41: 493-502.
[37]
Kuroda MJ. Macrophages: do they impact AIDS progression more than CD4 T cells? J Leukoc Biol 2010; 87: 569-73.
[38]
Nowlin BT, Burdo TH, Midkiff CC, et al. SIV encephalitis lesions are composed of CD163(+) macrophages present in the central nervous system during early SIV infection and SIV-positive macrophages recruited terminally with AIDS. Am J Pathol 2015; 185: 1649-65.
[39]
Desrosiers RC, Hansen-Moosa A, Mori K, et al. Macrophage-tropic Variants of SIV Are Associated with Specific AIDS-related Lesions but Are Not Essential for the Development of AIDS. Am J Pathol 1991; 139: 29-35.
[40]
Hrecka K, Hao C, Gierszewska M, et al. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 2011; 474: 658-61.
[41]
Laguette N, Sobhian B, Casartelli N, et al. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 2011; 474: 654-7.
[42]
Joseph SB, Arrildt KT, Swanstrom AE, et al. Quantification of entry phenotypes of macrophage-tropic HIV-1 across a wide range of CD4 densities. J Virol 2014; 88: 1858-69.
[43]
Thomas ER, Dunfee RL, Stanton J, et al. Macrophage entry mediated by HIV envs from brain and lymphoid tissues is determined by the capacity to use low CD4 levels and overall efficiency of fusion. Virology 2007; 360: 105-19.
[44]
Yen PJ, Herschhorn A, Haim H, et al. Loss of a conserved N-linked glycosylation site in the simian immunodeficiency virus envelope glycoprotein V2 region enhances macrophage tropism by increasing CD4-independent cell-to-cell transmission. J Virol 2014; 88: 5014-28.
[45]
Mori K, Ringler DJ, Kodama T, Desrosiers RC. Complex determinants of macrophage tropism in env of simian immunodeficiency virus. J Virol 1992; 66: 2067-75.
[46]
Johnson WE, Lifson JD, Lang SM, Johnson RP, Desrosiers RC. Importance of B-Cell responses for immunological control of variant strains of simian immunodeficiency virus. J Virol 2003; 77: 375-81.
[47]
Borda JT, Alvarez X, Kondova I, et al. Cell Tropism of Simian Immunodeficiency Virus in Culture Is Not Predictive of in vivo Tropism or Pathogenesis. American Journal of Pathology 2004; 165: 2111-22.
[48]
Ortiz AM, Klatt NR, Li B, et al. Depletion of CD4(+) T cells abrogates post-peak decline of viremia in SIV-infected rhesus macaques. J Clin Invest 2011; 121: 4433-45.
[49]
Francella N, Elliott STC, Yi Y, et al. Decreased plasticity of corecptor use by CD4-independent SIV Envs that emerge in vivo. Retrovirology 2013; 10(1): 133.
[50]
Puffer BA, Pohlmann S, Edinger AL, et al. CD4 Independence of simian immunodeficiency virus envs is associated with macrophage tropism, neutralization sensitivity, and attenuated pathogenicity. J Virol 2002; 76: 2595-605.
[51]
Edwards TG, Hoffman TL, Baribaud F, et al. Relationships between CD4 independence, neutralization sensitivity, and exposure of a CD4-induced epitope in a human immunodeficiency virus type 1 envelope protein. J Virol 2001; 75: 5230-9.
[52]
Kolchinsky P, Kiprilov E, Sodroski J. Increased neutralization sensitivity of CD4-independent human immunodeficiency virus variants. J Virol 2001; 75: 2041-50.
[53]
White TA, Bartesaghi A, Borgnia MJ, et al. Molecular architectures of trimeric SIV and HIV-1 envelope glycoproteins on intact viruses: strain-dependent variation in quaternary structure. PLoS Pathog 2010; 6: e1001249.
[54]
Micci L, Alvarez X, Iriele RI, et al. CD4 depletion in SIV-infected macaques results in macrophage and microglia infection with rapid turnover of infected cells. PLoS Pathog 2014; 10: e1004467.
[55]
Burdo TH, Lackner A, Williams KC. Monocyte/macrophages and their role in HIV neuropathogenesis. Immunol Rev 2013; 254: 102-13.
[56]
Klatt NR, Funderburg NT, Brenchley JM. Microbial translocation, immune activation, and HIV disease. Trends Microbiol 2013; 21: 6-13.
[57]
Klatt NR, Brenchley JM. Th17 cell dynamics in HIV infection. Curr Opin HIV AIDS 2010; 5: 135-40.
[58]
Paiardini M, Frank I, Pandrea I, Apetrei C, Silvestri G. Mucosal Immune Dysfunction in AIDS Pathogenesis. AIDS Reviews 2008; 10: 36-46.
[59]
Postler TS, Desrosiers RC. The cytoplasmic domain of the HIV-1 glycoprotein gp41 induces NF-kappaB activation through TGF-beta-activated kinase 1. Cell Host Microbe 2012; 11: 181-93.
[60]
Marsh M, Pelchen-Matthews A, Hoxie JA. Roles of endocytosis in lentiviral replication. Trends Cell Biol 1997; 7: 1-4.
[61]
Boge M, Wyss S, Bonifacino JS, Thali M. A membrane-proximal tyrosine-based signal mediates internalization of the HIV-1 envelope glycoprotein via interaction with the AP-2 Clathrin Adaptor. J Biol Chem 1998; 273: 15773-8.
[62]
Tedbury PR, Ablan SD, Freed EO. Global rescue of defects in HIV-1 envelope glycoprotein incorporation: implications for matrix structure. PLoS Pathog 2013; 9: e1003739.
[63]
Wyss S, Berlioz-Torrent C, Boge M, et al. The highly conserved C-terminal dileucine motif in the cytosolic domain of the human immunodeficiency virus type 1 envelope glycoprotein is critical for its association with the AP-1 clathrin adaptor.[correction of adapter]. J Virol 2001; 75: 2982-92.
[64]
Byland R, Vance PJ, Hoxie JA, Marsh M. A Conserved Dileucine Motif Mediates Clathrin and AP-2-dependent Endocytosis of the HIV-1 Envelope Protein. Mol Biol Cell 2007; 18: 414-25.
[65]
Ohno H, Aguilar RC, Fournier M-C, et al. Interaction of endocytic signals from the HIV-1 envelope glycoprotein complex with members of the adaptor medium chain family. Virology 1997; 238: 305-15.
[66]
Evans DT, Tillman KC, Desrosiers RC. Envelope Glycoprotein Cytoplasmic Domains from Diverse Lentiviruses Interact with the Prenylated Rab Acceptor. J Virol 2002; 76: 327-37.
[67]
Qi M, Chu H, Chen X, et al. A tyrosine-based motif in the HIV-1 envelope glycoprotein tail mediates cell-type- and Rab11-FIP1C-dependent incorporation into virions. Proc Natl Acad Sci USA 2015; 112: 7575-80.
[68]
Postler TS, Desrosiers RC. The tale of the long tail: the cytoplasmic domain of HIV-1 gp41. J Virol 2013; 87: 2-15.
[69]
Do T, Murphy G, Earl LA, et al. Three-dimensional imaging of HIV-1 virological synapses reveal membrane architectures involved in virus transmission. J Virol 2014; 88: 10327-39.
[70]
Deschambeault J, Lalonde J-P, Cervantes-Acosta G, et al. Polarized human immunodeficiency virus budding in lymphocytes involves a tyrosine-based signal and favors cell-to-cell viral transmission. J Virol 1999; 73: 5010-7.
[71]
Lodge R, Gottlinger H, Gabuzda D, Cohen EA, Lemay G. The intracytoplasmic domain of gp41 mediates polarized budding of human immunodeficiency virus type 1 in MDCK Cells. J Virol 1994; 68: 4857-61.
[72]
Sherer NM, Lehmann MJ, Jimenez-Soto LF, et al. Retroviruses can establish filopodial bridges for efficient cell-to-cell transmission. Nat Cell Biol 2007; 9: 310-5.
[73]
Mothes W, Sherer NM, Jin J, Zhong P. Virus cell-to-cell transmission. J Virol 2010; 84: 8360-8.
[74]
Fultz PN, Vance PJ, Endres MJ, et al. In vivo attenuation of simian immunodeficiency virus by disruption of a tyrosine-dependent sorting signal in the envelope glycoprotein cytoplasmic tail. J Virol 2001; 75: 278-91.
[75]
Breed MW, Jordan APO, Aye PP, et al. Loss of a tyrosine-dependent trafficking motif in the simian immunodeficiency virus envelope cytoplasmic tail spares mucosal CD4 cells but does not prevent disease progression. J Virol 2013; 87: 1528-43.
[76]
Breed MW, Elser SE, Torben W, et al. Elite Control, Gut CD4 T Cell Sparing, and Enhanced Mucosal T Cell Responses in Macaca nemestrina Infected by a Simian Immunodeficiency Virus Lacking a gp41 Trafficking Motif. J Virol 2015; 89: 10156-75.
[77]
Klatt NR, Canary LA, Vanderford TH, et al. Dynamics of simian immunodeficiency virus SIVmac239 infection in pigtail macaques. J Virol 2012; 86: 1203-13.
[78]
Yen PJ, Mefford ME, Hoxie JA, et al. Identification and characterization of a macrophage-tropic SIV envelope glycoprotein variant in blood from early infection in SIVmac251-infected macaques. Virology 2014; 458-459: 53-68.
[79]
Keele BF, Giorgi EE, Salazar-Gonzalez JF, et al. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci 2008; 105: 7552-7.
[80]
Schuitemaker H, van ’t Wout AB, Lusso P. Clinical significance of HIV-1 coreceptor usage. J Transl Med 2011; 9(Suppl. 1): S5.
[81]
Connor RI, Sheridan KE, Ceradini D, Choe S, Landau NR. Change in coreceptor use correlates with disease progression in HIV-1-infected Individuals. J Exp Med 1997; 185: 621-8.
[82]
Huang W, Eshleman SH, Toma J, et al. Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations. J Virol 2007; 81: 7885-93.
[83]
Cardozo T, Kimura T, Philpott S, et al. Structural basis for coreceptor selectivity by the HIV type 1 V3 loop. AIDS Res Hum Retroviruses 2007; 23: 415-26.
[84]
Jensen MA, Li FS, van ’t Wout AB, et al. Improved Coreceptor Usage Prediction and Genotypic Monitoring of R5-to-X4 Transition by Motif Analysis of Human Immunodeficiency Virus Type 1 env V3 Loop Sequences. J Virol 2003; 77: 13376-88.
[85]
Resch W, Hoffman N, Swanstrom R. Improved success of phenotype prediction of the human immunodeficiency virus type 1 from envelope variable loop 3 sequence using neural networks. Virology 2001; 288: 51-62.
[86]
Picker LJ, Hagen SI, Lum R, et al. Insufficient production and tissue delivery of CD4+ memory T cells in rapidly progressive simian immunodeficiency virus infection. J Exp Med 2004; 200: 1299-314.
[87]
Blaak H, van’t Wout AB, Brouwer M, et al. In vivo HIV-1 infection of CD45RA+ CD4+ T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4+ T cell decline. Proc Natl Acad Sci 2000; 97: 1269-74.
[88]
LaCasse RA, Follis KE, Moudgil T, et al. Coreceptor utilization by human immunodeficiency virust type 1 Is not a primary determinant of neutralization sensitivity. J Virol 1998; 72: 2491-5.
[89]
Montefiori DC, Collman RG, Fouts TR, et al. Evidence that antibody-mediated neutralization of human immunodeficiency virus type 1 by sera from infected individuals is independent of coreceptor usage. J Virol 1998; 72: 1886-93.
[90]
Trkola A, Ketas TJ, KewalRamani VN, et al. Neutralization sensitivity of human immunodeficiency virus type 1 primary isolates to antibodies and CD4-Based Reagents is independent of coreceptor usage. J Virol 1998; 72: 1876-85.
[91]
Bunnik EM, Quakkelaar ED, van Nuenen AC, Boeser-Nunnink B, Schuitemaker H. Increased neutralization sensitivity of recently emerged CXCR4-using human immunodeficiency virus type 1 strains compared to coexisting CCR5-using variants from the same patient. J Virol 2007; 81: 525-31.
[92]
Cavacini LA, Duval M, Robinson J, Posner MR. Interactions of human antibodies, epitope exposure, antibody binding and neutralization of primary isolate HIV-1 virions. AIDS 2002; 16: 2409-17.
[93]
Lin N, Gonzalez OA, Registre L, et al. Humoral immune pressure selects for HIV-1 CXC-chemokine receptor 4-using variants. EBioMedicine 2016; 8: 237-47.
[94]
Chen Z, Zhou P, Ho DD, Landau NR, Marx PA. Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. J Virol 1997; 71: 2705-14.
[95]
Joag SV, Li Z, Foresman L, et al. Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4+ T Cells and AIDS in pig-tailed macaques. J Virol 1996; 70: 3189-97.
[96]
Shibata R, Maldarelli F, Siemon C, et al. Infection and pathogenicity of chimeric simian-human immunodeficiency viruses in macaques: determinants of high virus loads and CD4 Cell killing. J Infect Dis 1997; 176: 362-73.
[97]
Meister S, Otto C, Papkalla A, et al. Basic amino acid residues in the V3 loop of simian immunodeficiency virus envelope alter viral coreceptor tropism and infectivity but do not allow efficient utilization of CXCR4 as entry cofactor. Virology 2001; 284(2): 287-96.
[98]
Kirchhoff F, Mori K, Desrosiers RC. The “V3” Domain Is a determinant of simian immunodeficiency virus cell tropism. J Virol 1994; 68: 3682-92.
[99]
DeGottardi MQ, Lew SK, Piatak M Jr, et al. Comparison of plasma viremia and antibody responses in macaques inoculated with envelope variants of single-cycle simian immunodeficiency virus differing in infectivity and cellular tropism. J Virol 2008; 82: 321-34.
[100]
Means RE, Matthews T, Hoxie JA, et al. Ability of the V3 loop of simian immunodeficiency virus to serve as a target for antibody-mediated neutralization: correlation of neutralization sensitivity, growth in macrophages, and decreased dependence on CD4. J Virol 2001; 75: 3903-15.
[101]
Del Prete GQ, Haggarty B, Leslie GJ, et al. Derivation and characterization of a simian immunodeficiency virus SIVmac239 variant with tropism for CXCR4. J Virol 2009; 83: 9911-22.
[102]
Kwong PD, Wyatt R, Robinson J, et al. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 1998; 393: 648-59.
[103]
Lyumkis D, Julien JP, de Val N, et al. Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer. Science 2013; 342: 1484-90.
[104]
Kwon YD, Pancera M, Acharya P, et al. Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env. Nat Struct Mol Biol 2015; 22: 522-31.
[105]
Decker JM, Bibollet-Ruche F, Wei X, et al. Antigenic conservation and immunogenicity of the HIV coreceptor binding site. J Exp Med 2005; 201: 1407-19.
[106]
Liu J, Bartesaghi A, Borgnia MJ, Sapiro G, Subramaniam S. Molecular architecture of native HIV-1 gp120 trimers. Nature 2008; 455: 109-13.
[107]
Labrijn AF, Poignard P, Raja A, et al. Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1. J Virol 2003; 77: 10557-65.
[108]
Kalams SA, Walker BD. The Critical Need for CD4 Help in Maintaining Effective Cytotoxic T Lymphocyte Responses. J Exp Med 1998; 188: 2199-204.
[109]
Heeney JL. The critical role of CD4+ T-cell help in immunity to HIV. Vaccine 2002; 20: 1961-3.
[110]
Altfeld M, Rosenberg ES. The role of CD4+ T helper cells in the cytotoxic T lymphocyte response to HIV-1. Curr Opin Immunol 2000; 12: 375-80.
[111]
Onabajo OO, Mattapallil JJ. Expansion or depletion of T follicular helper cells during HIV infection: Consequences for B cell responses. Curr HIV Rese 2013; 11: 595-600.
[112]
Endres MJ, Clapham PR, Marsh M, et al. CD4-Independent infection by HIV-2 Is mediated by fusin/CXCR4. Cell 1996; 87: 745-56.
[113]
LaBranche CC, Hoffman TL, Romano J, et al. Determinants of CD4 independence for a human immunodeficiency virus type 1 variant map outside regions required for coreceptor specificity. J Virol 1999; 73: 10310-9.
[114]
Puffer BA, Altamura LA, Pierson TC, Doms RW. Determinants within gp120 and gp41 contribute to CD4 independence of SIV Envs. Virology 2004; 327: 16-25.
[115]
Kolchinsky P, Mirzabekov T, Farzan M, et al. Adaptation of a CCR5-using, primary human immunodeficiency virus type 1 isolate for CD4-Independent replication. J Virol 1999; 73: 8120-6.
[116]
Dumonceaux J, Nisole S, Chanel C, et al. Spontaneous mutations in the env gene of the human immunodeficiency virus type 1 NDK isolate are Associated with a CD4-Independent Entry Phenotype. J Virol 1998; 72: 512-9.
[117]
Boyd DF, Peterson D, Haggarty BS, et al. Mutations in HIV-1 envelope that enhance entry with the macaque CD4 receptor alter antibody recognition by disrupting quaternary interactions within the trimer. J Virol 2015; 89: 894-907.
[118]
Swanstrom AE, Haggarty B, Jordan AP, et al. Derivation and characterization of a CD4-independent, non-CD4-tropic simian immunodeficiency virus. J Virol 2016; 90: 4966-80.
[119]
Li Y, Migueles SA, Welcher B, et al. Broad HIV-1 neutralization mediated by CD4-binding site antibodies. Nat Med 2007; 13: 1032-4.
[120]
Olshevsky U, Helseth E, Furman C, et al. Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 Receptor Binding. J Virol 1990; 64: 5701-7.
[121]
Silver ZA, Watkins DI. The role of MHC class I gene products in SIV infection of macaques. Immunogenetics 2017; 69: 511-9.
[122]
Dzuris JL, Sidney J, Horton H, et al. Molecular determinants of peptide binding to two common rhesus macaque major histocompatibility complex class II molecules. J Virol 2001; 75: 10958-68.
[123]
Erdmann N, Du VY, Carlson J, et al. HLA Class-II Associated HIV Polymorphisms Predict Escape from CD4+ T Cell Responses. PLoS Pathog 2015; 11: e1005111.
[124]
Jones RB, Yue FY, Gu XX, et al. Human immunodeficiency virus type 1 escapes from interleukin-2-producing CD4+ T-cell responses without high-frequency fixation of mutations. J Virol 2009; 83: 8722-32.
[125]
Burwitz BJ, Giraldo-Vela JP, Reed J, et al. CD8+ and CD4+ cytotoxic T cell escape mutations preced breakthrough SIVmac239 viremia in an elite controller. Retrovirology 2012; 9: 1-11.
[126]
Giraldo-Vela JP, Rudersdorf R, Chung C, et al. The major histocompatibility complex class II alleles Mamu-DRB1*1003 and -DRB1*0306 are enriched in a cohort of simian immunodeficiency virus-infected rhesus macaque elite controllers. J Virol 2008; 82: 859-70.
Related Books
Frontiers in Clinical Drug Research: Anti-Infectives
Frontiers in Anti-Infective Drug Discovery
Coronaviruses
Moving From COVID-19 Mathematical Models to Vaccine Design: Theory, Practice and Experiences
COVID-19: Effects in Comorbidities and Special Populations
An Update on SARS-CoV-2: Damage-response Framework, Potential Therapeutic Avenues and the Impact of Nanotechnology on COVID-19 Therapy
An Epidemiological Update on COVID -19
Frontiers in Clinical Drug Research: Anti-Infectives
Frontiers in Anti-infective Agents
Coronavirus Disease-19 (COVID-19): A Perspective of New Scenario
Article Metrics
58
27
2
2